Biofeedback treatment for shortness of breath
Open Trial of Biofeedback for Respiratory Symptoms
This study is testing a six-session biofeedback program to see if it can help people with shortness of breath feel better when other treatments haven't worked.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 25 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT05973513 on ClinicalTrials.gov |
What this trial studies
This observational study explores the use of a six-session biofeedback protocol aimed at helping patients with respiratory symptoms, specifically shortness of breath, who have not found relief through traditional medical treatments. The protocol includes heart-rate variability biofeedback, respiration and relaxation training, and body temperature control. Participants will complete questionnaires before, after, and three months post-treatment to assess changes in somatic symptoms and self-rated mental health outcomes. The study aims to evaluate the effectiveness of biofeedback in improving patients' quality of life and reducing healthcare utilization.
Who should consider this trial
Good fit: Ideal candidates are English-speaking adults aged 18-60 who have at least one respiratory symptom and have received care from a pulmonologist.
Not a fit: Patients with severe psychopathology or those who do not meet the age or language criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide patients with a non-pharmacological method to alleviate respiratory symptoms and improve their overall mental health.
How similar studies have performed: While biofeedback has been explored in various contexts, this specific application for respiratory symptoms is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. participants must be between 18-60 2. English speaking 3. must have least one respiratory sx and have received care from a pulmonologist for this sx Exclusion Criteria: severe psychopathology (e.g., psychosis, active suicidality, moderate to severe intellectual impairment).
Where this trial is running
Los Angeles, California
- Natacha Emerson — Los Angeles, California, United States (Recruiting)
Study contacts
- Study coordinator: Natacha D Emerson, PhD
- Email: ndemerson@mednet.ucla.edu
- Phone: 310-794-8416
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.